Piramal Pharma share news and announcements
NSE: PPLPHARMABSE: 543635Pharmaceuticals & BiotechnologySmall Cap
Last close ₹191.07down ₹3.92 (2.01%)BSE ₹190.85
Share price at the NSE close on 23 Oct 2026. Previous close ₹194.99.
52-week range of traded prices to 23 Oct 2026
₹132.30Low, 23 Mar 2026₹231.93High, 8 Sep 2026
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹25,438 Cr331st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 Apr 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 29 Jul 2026
- −3.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹217 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −1.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 29 Jul 2026
- 1.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 Apr 2026
- 0.67
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 24,65,51342.5% delivered
Next board meeting and results date
As the company gave notice to the exchange.Piramal Pharma quarterly results
Oct27Tue
The board meets on 27 Oct 2026 to consider financial results
Notice filed 16 Oct 2026
Piramal Pharma annual reports, presentations and earnings calls
The company's own documents, latest first.Piramal Pharma financials, year by year
Annual reports4
- Annual report, year to Mar 2026 (opens in a new tab)3 Jul 2026
- Annual report, year to Mar 2025 (opens in a new tab)2 Jul 2025
- Annual report, year to Mar 2024 (opens in a new tab)2 Jul 2024
- Annual report, year to Mar 2023 (opens in a new tab)6 Jul 2023, a zip file
Investor presentations16
- Investor Presentation (opens in a new tab)29 Jul 2026
- Investor Presentation (opens in a new tab)28 Apr 2026
- Investor Presentation (opens in a new tab)29 Jan 2026
- Investor Presentation (opens in a new tab)5 Nov 2025
- Investor Presentation (opens in a new tab)28 Jul 2025
11 earlier presentations
- Investor Presentation (opens in a new tab)14 May 2025
- Investor Presentation (opens in a new tab)28 Jan 2025
- Investor Presentation (opens in a new tab)23 Oct 2024
- Investor Presentation (opens in a new tab)24 Sep 2024
- Investor Presentation (opens in a new tab)26 Jul 2024
- Investor Presentation (opens in a new tab)10 May 2024
- Investor Presentation (opens in a new tab)30 Jan 2024
- Investor Presentation (opens in a new tab)27 Oct 2023
- Investor Presentation (opens in a new tab)3 Aug 2023
- Investor Presentation (opens in a new tab)24 May 2023
- Investor Presentation (opens in a new tab)5 Jan 2023
Earnings calls33
- Transcript (opens in a new tab)31 Jul 2026
- Link of Recording (opens in a new tab)30 Jul 2026
- Transcript of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026 (opens in a new tab)30 Apr 2026
- Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026 (opens in a new tab)29 Apr 2026
- Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026 (opens in a new tab)29 Apr 2026
28 earlier call documents
- Transcript (opens in a new tab)30 Jan 2026
- Link of Recording (opens in a new tab)29 Jan 2026
- Transcript (opens in a new tab)7 Nov 2025
- Link of Recording (opens in a new tab)6 Nov 2025
- Transcript (opens in a new tab)31 Jul 2025
- Link of Recording (opens in a new tab)29 Jul 2025
- Transcript (opens in a new tab)16 May 2025
- Link of Recording (opens in a new tab)15 May 2025
- Transcript (opens in a new tab)30 Jan 2025
- Link of Recording (opens in a new tab)29 Jan 2025
- Transcript (opens in a new tab)26 Oct 2024
- Link of Recording (opens in a new tab)24 Oct 2024
- Transcript (opens in a new tab)29 Jul 2024
- Link of Recording (opens in a new tab)26 Jul 2024
- Transcript (opens in a new tab)14 May 2024
- Link of Recording (opens in a new tab)13 May 2024
- Transcript (opens in a new tab)2 Feb 2024
- Link of Recording (opens in a new tab)31 Jan 2024
- Transcript (opens in a new tab)31 Oct 2023
- Link of Recording (opens in a new tab)30 Oct 2023
- Transcript (opens in a new tab)7 Aug 2023
- Link of Recording (opens in a new tab)4 Aug 2023
- Transcript (opens in a new tab)29 May 2023
- Link of Recording (opens in a new tab)25 May 2023
- Transcript (opens in a new tab)13 Feb 2023
- Link of Recording (opens in a new tab)9 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)11 Nov 2022
- Audio Recording of Analysts/Institutional Investor Meet/Con. Call (opens in a new tab)9 Nov 2022
Piramal Pharma share news and announcements
317 announcements, routine notices left out, newest first. Page 1 of 7.
Oct 2026
16 Oct · Analysts
1 Oct · News Verification
The exchange asked on 30 Sep 2026
Sep 2026
Aug 2026
18 Aug · Business
Jul 2026
24 Jul · Updates
20 Jul · Analysts
Jun 2026
23 Jun · News Verification
The exchange asked on 23 Jun 2026
5 Jun · Disclosure
May 2026
Apr 2026
28 Apr · Board meeting
17 Apr · Analysts
Mar 2026
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 1 Oct 2026Board or managers changeddown 4.14%−3.2 pts vs Nifty 500market median 0.0% · five sessions −4.9% (−2.8 pts vs Nifty 500) · volume 0.8× usual · delivery +0.7 pts against usual · The announcement (opens in a new tab)
- 30 Jul 2026Resultsup 0.53%+0.5 pts vs Nifty 500market median −0.7% · five sessions +5.7% (+4.0 pts vs Nifty 500) · volume 2.7× usual · delivery −12.5 pts against usual · The announcement (opens in a new tab)
- 29 Apr 2026Resultsdown 2.63%−3.1 pts vs Nifty 500market median −0.7% · five sessions +0.4% (−1.2 pts vs Nifty 500) · volume 1.0× usual · delivery −3.3 pts against usual · The announcement (opens in a new tab)
- 5 Feb 2026Board or managers changeddown 2.20%−1.7 pts vs Nifty 500market median 0.0% · five sessions +1.4% (+0.3 pts vs Nifty 500) · volume 0.5× usual · delivery −5.2 pts against usual · The announcement (opens in a new tab)
- 29 Jan 2026Board or managers changeddown 0.18%−0.4 pts vs Nifty 500market median 0.0% · five sessions +4.7% (+3.1 pts vs Nifty 500) · volume 5.7× usual · delivery −18.2 pts against usual · The announcement (opens in a new tab)
- 29 Jan 2026Resultsdown 0.18%−0.4 pts vs Nifty 500market median −0.7% · five sessions +4.7% (+3.1 pts vs Nifty 500) · volume 5.7× usual · delivery −18.2 pts against usual · The announcement (opens in a new tab)
- 6 Nov 2025Resultsdown 0.54%+0.1 pts vs Nifty 500market median −0.7% · five sessions −2.4% (−3.1 pts vs Nifty 500) · volume 4.8× usual · delivery −8.1 pts against usual · The announcement (opens in a new tab)
- 17 Oct 2025Credit ratingdown 0.78%−0.9 pts vs Nifty 500market median 0.0% · five sessions +4.2% (+3.7 pts vs Nifty 500) · volume 0.5× usual · delivery −13.3 pts against usual · The announcement (opens in a new tab)
- 29 Jul 2025Resultsup 0.62%−0.1 pts vs Nifty 500market median −0.7% · five sessions −4.6% (−4.6 pts vs Nifty 500) · volume 2.9× usual · delivery −16.9 pts against usual · The announcement (opens in a new tab)
- 21 Jul 2025Credit ratingup 0.25%−0.2 pts vs Nifty 500market median 0.0% · five sessions −4.2% (−3.1 pts vs Nifty 500) · volume 1.5× usual · delivery +14.6 pts against usual · The announcement (opens in a new tab)
15 earlier announcements
- 15 May 2025Resultsdown 4.76%−6.0 pts vs Nifty 500market median −0.7% · five sessions −5.9% (−6.9 pts vs Nifty 500) · volume 4.1× usual · delivery +8.7 pts against usual · The announcement (opens in a new tab)
- 15 May 2025Dividenddown 4.76%−6.0 pts vs Nifty 500market median 0.0% · five sessions −5.9% (−6.9 pts vs Nifty 500) · volume 4.1× usual · delivery +8.7 pts against usual · The announcement (opens in a new tab)
- 15 May 2025Board or managers changeddown 4.76%−6.0 pts vs Nifty 500market median 0.0% · five sessions −5.9% (−6.9 pts vs Nifty 500) · volume 4.1× usual · delivery +8.7 pts against usual · The announcement (opens in a new tab)
- 29 Jan 2025Resultsup 9.49%+8.0 pts vs Nifty 500market median −0.7% · five sessions +6.0% (+3.7 pts vs Nifty 500) · volume 2.8× usual · delivery −18.6 pts against usual · The announcement (opens in a new tab)
- 7 Jan 2025Board or managers changedup 1.15%+0.6 pts vs Nifty 500market median 0.0% · five sessions −6.1% (−1.6 pts vs Nifty 500) · volume 0.5× usual · delivery +4.0 pts against usual · The announcement (opens in a new tab)
- 24 Oct 2024Resultsup 17.36%+17.6 pts vs Nifty 500market median −0.7% · five sessions +15.8% (+16.2 pts vs Nifty 500) · volume 13.2× usual · delivery −19.0 pts against usual · The announcement (opens in a new tab)
- 22 Oct 2024Credit ratingdown 5.69%−3.8 pts vs Nifty 500market median 0.0% · five sessions +8.0% (+10.7 pts vs Nifty 500) · volume 0.7× usual · delivery +5.6 pts against usual · The announcement (opens in a new tab)
- 9 Oct 2024Board or managers changeddown 0.01%−0.4 pts vs Nifty 500market median 0.0% · five sessions +3.3% (+2.3 pts vs Nifty 500) · volume 0.8× usual · delivery +34.7 pts against usual · The announcement (opens in a new tab)
- 2 Aug 2024Credit ratingup 0.59%+1.6 pts vs Nifty 500market median 0.0% · five sessions +6.8% (+10.2 pts vs Nifty 500) · volume 0.8× usual · delivery −3.6 pts against usual · The announcement (opens in a new tab)
- 26 Jul 2024Resultsup 0.13%−1.5 pts vs Nifty 500market median −0.7% · five sessions +4.2% (+1.6 pts vs Nifty 500) · volume 6.0× usual · delivery −20.5 pts against usual · The announcement (opens in a new tab)
- 13 May 2024Dividendup 2.49%+2.3 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−3.3 pts vs Nifty 500) · volume 9.3× usual · delivery −17.8 pts against usual · The announcement (opens in a new tab)
- 13 May 2024Board or managers changedup 2.49%+2.3 pts vs Nifty 500market median 0.0% · five sessions −0.4% (−3.3 pts vs Nifty 500) · volume 9.3× usual · delivery −17.8 pts against usual · The announcement (opens in a new tab)
- 31 Jan 2024Resultsup 3.78%+2.6 pts vs Nifty 500market median −0.7% · five sessions +1.4% (−1.0 pts vs Nifty 500) · volume 3.0× usual · delivery −10.6 pts against usual · The announcement (opens in a new tab)
- 4 Aug 2023Resultsdown 2.41%−3.1 pts vs Nifty 500market median −0.7% · five sessions −5.9% (−6.9 pts vs Nifty 500) · volume 0.8× usual · delivery +3.0 pts against usual · The announcement (opens in a new tab)
- 8 Mar 2023Credit ratingdown 2.56%−2.8 pts vs Nifty 500market median 0.0% · five sessions −12.1% (−8.6 pts vs Nifty 500) · volume 0.9× usual · delivery +22.3 pts against usual · The announcement (opens in a new tab)
Piramal Pharma results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.